A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study.

Source:http://linkedlifedata.com/resource/pubmed/id/20109071

Download in:

View as

General Info

PMID
20109071